MedTrace Logo

Individualized Homeopathy to Reduce the Use of Antibiotics in Women With Recurrent Uncomplicated Urinary Tract Infections

NCT05545514 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2024-11-08

No results posted yet for this study

Summary

The aim of the study is to determine the efficacy of individualised homeopathic drug treatment (potency C200 and C1000) compared to placebo in females (age 18\<65) with recurrent urinary tract infections, per definition ≥ 2 UTI in 6 months and/ or ≥ 3 UTI in 9 months.

Conditions

  • Urinary Tract Infection Chronic

Interventions

DRUG

One out of 140 predefined homeopathic medical products (HMP) in potency C200 or C1000,

To investigate the efficacy of individualised homeopathic treatment (potency C200 and/or C1000) in comparison to placebo regarding the number of UTI treated with antibiotic agents.

Sponsors & Collaborators

  • School of Medicine, Technical University Munich, Münchner Studienzentrum

    collaborator UNKNOWN

  • Klinikum rechts der Isar, TUM Institute for AI and Informatics in Medicine (AIIM)

    collaborator UNKNOWN

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Lutz Renders, Prof. Dr. med. · Klinikum rechts der Isar, TUM, Department Nephrology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2025-01-30
Completion
2026-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05545514 on ClinicalTrials.gov